L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells

Neuropharmacology

Volumn 67, Issue , 2013, Pages 243-251

  Stansley, Branden J ^a   Yamamoto, Bryan K ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Cell death; Dopamine; L dopa; Reactive oxygen species; RN46A B14 cells; Serotonin

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AROMATIC LEVO AMINO ACID DECARBOXYLASE; CELL PROTEIN; LEVODOPA; QUINOPROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; BIOACCUMULATION; CELL DEATH; CELL IMMORTALIZATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOFLUORESCENCE TEST; MOLECULAR DYNAMICS; NERVE CELL DIFFERENTIATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SEROTONINERGIC NERVE CELL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CELL LINE, TRANSFORMED; DOPAMINE; HUMANS; LEVODOPA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SEROTONERGIC NEURONS;

EID: 84873391836     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.11.010     Document Type: Article

References (39)

1. A. Antonini, P. Barone, R. Marconi, L. Morgante, S. Zappulla, F.E. Pontieri, S. Ramat, M.G. Ceravolo, G. Meco, G. Cicarelli, M. Pederzoli, M. Manfredi, R. Ceravolo, M. Mucchiut, G. Volpe, G. Abbruzzese, E. Bottacchi, L. Bartolomei, G. Ciacci, A. Cannas, M.G. Randisi, A. Petrone, M. Baratti, V. Toni, G. Cossu, P. Del Dotto, A.R. Bentivoglio, M. Abrignani, R. Scala, F. Pennisi, R. Quatrale, R.M. Gaglio, A. Nicoletti, M. Perini, T. Avarello, A. Pisani, A. Scaglioni, P.E. Martinelli, F. Iemolo, L. Ferigo, P. Simone, P. Soliveri, B. Troianiello, D. Consoli, A. Mauro, L. Lopiano, G. Nastasi, and C. Colosimo The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life J. Neurol. 259 2012 2621 2631
2. R. Arai, N. Karasawa, M. Geffard, and I. Nagatsu L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study Neurosci. Lett. 195 1995 195 198
3. M. Asanuma, I. Miyazaki, and N. Ogawa Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease Neurotox. Res. 5 2003 165 176
4. A.N. Basma, E.J. Morris, W.J. Nicklas, and H.M. Geller L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation J. Neurochem. 64 1995 825 832
5. S.B. Berman, and T.G. Hastings Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease J. Neurochem. 73 1999 1127 1137
6. S.B. Berman, M.J. Zigmond, and T.G. Hastings Modification of dopamine transporter function: effect of reactive oxygen species and dopamine J. Neurochem. 67 1996 593 600
7. A. Borah, and K.P. Mohanakumar Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats Cell. Mol. Neurobiol. 27 2007 985 996
8. M. Carta, T. Carlsson, D. Kirik, and A. Bjorklund Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats Brain 130 2007 1819 1833
9. J.J. Chen, D.M. Swope, and K. Dashtipour Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease Clin. Ther. 29 2007 1825 1849
10. L. Chen, Y. Ding, B. Cagniard, A.D. Van Laar, A. Mortimer, W. Chi, T.G. Hastings, U.J. Kang, and X. Zhuang Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice J. Neurosci. 28 2008 425 433
11. M. De Marinis, F. Stocchi, S.R. Testa, F. De Pandis, and A. Agnoli Alterations of thermoregulation in Parkinson's disease Funct. Neurol. 6 1991 279 283
12. M.J. Eaton, J.K. Staley, M.Y. Globus, and S.R. Whittemore Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization Dev. Biol. 170 1995 169 182
13. M.J. Eaton, and S.R. Whittemore Autocrine BDNF secretion enhances the survival and serotonergic differentiation of raphe neuronal precursor cells grafted into the adult rat CNS Exp. Neurol. 140 1996 105 114
14. K.L. Eskow Jaunarajs, J.A. George, and C. Bishop L-DOPA-induced dyregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease Neuroscience 218 2012 243 256
15. D.G. Graham Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones Mol. Pharmacol. 14 1978 633 643
16. M.J. Jou, S.B. Jou, H.M. Chen, C.H. Lin, and T.I. Peng Critical role of mitochondrial reactive oxygen species formation in visible laser irradiation-induced apoptosis in rat brain astrocytes (RBA-1) J. Biomed. Sci. 9 2002 507 516
17. A.V. Juorio, X.M. Li, W. Walz, and I.A. Paterson Decarboxylation of L-dopa by cultured mouse astrocytes Brain Res. 626 1993 306 309
18. D.M. Kuhn, and R. Arthur Jr. Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons J. Neurosci. 18 1998 7111 7117
19. H. Maharaj, D. Sukhdev Maharaj, M. Scheepers, R. Mokokong, and S. Daya L-DOPA administration enhances 6-hydroxydopamine generation Brain Res. 1063 2005 180 186
20. M.A. Mena, B. Pardo, M.J. Casarejos, S. Fahn, and J. Garcia de Yebenes Neurotoxicity of levodopa on catecholamine-rich neurons Mov. Disord. 7 1992 23 31
21. D.W. Miller, and E.D. Abercrombie Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats J. Neurochem. 72 1999 1516 1522
22. E.V. Mosharov, K.E. Larsen, E. Kanter, K.A. Phillips, K. Wilson, Y. Schmitz, D.E. Krantz, K. Kobayashi, R.H. Edwards, and D. Sulzer Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons Neuron 62 2009 218 229
23. A. Mura, D. Jackson, M.S. Manley, S.J. Young, and P.M. Groves Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-DOPA to dopamine Brain Res. 704 1995 51 60
24. S. Navailles, B. Bioulac, C. Gross, and P. De Deurwaerdere Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease Neurobiol. Dis. 38 2010 136 143
25. S. Navailles, B. Bioulac, C. Gross, and P. De Deurwaerdere Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease Neurobiol. Dis. 41 2011 585 590
26. K.Y. Ng, T.N. Chase, R.W. Colburn, and I.J. Kopin L-Dopa-induced release of cerebral monoamines Science 170 1970 76 77
27. D. Nyholm, H. Lennernas, C. Gomes-Trolin, and S.M. Aquilonius Levodopa pharmacokinetics and motor performance during activities of daily living in patients with Parkinson's disease on individual drug combinations Clin. Neuropharmacol. 25 2002 89 96
28. M.A. Paz, R. Fluckiger, A. Boak, H.M. Kagan, and P.M. Gallop Specific detection of quinoproteins by redox-cycling staining J. Biol. Chem. 266 1991 689 692
29. C.S. Peritore, A. Ho, B.K. Yamamoto, and S.E. Schaus Resveratrol attenuates L-DOPA-induced hydrogen peroxide toxicity in neuronal cells Neuroreport 23 2012 989 994
30. R. Pedrosa, and P. Soares-da-Silva Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine Br. J. Pharmacol. 137 2002 1305 1313
31. A. Schrag Quality of life and depression in Parkinson's disease J. Neurol. Sci. 248 2006 151 157
32. Y.L. Siow, and K. Dakshinamurti Neuronal dopa decarboxylase Ann. N. Y. Acad. Sci. 585 1990 173 188
33. A.H. Stokes, T.G. Hastings, and K.E. Vrana Cytotoxic and genotoxic potential of dopamine J. Neurosci. Res. 55 1999 659 665
34. A. Storch, H. Blessing, M. Bareiss, S. Jankowski, Z.D. Ling, P. Carvey, and J. Schwarz Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons Mol. Pharmacol. 57 2000 589 594
35. H. Tanaka, K. Kannari, T. Maeda, M. Tomiyama, T. Suda, and M. Matsunaga Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats Neuroreport 10 1999 631 634
36. D.A. Tata, J. Raudensky, and B.K. Yamamoto Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia Eur. J. Neurosci. 26 2007 739 748
37. L.A. White, M.J. Eaton, M.C. Castro, K.J. Klose, M.Y. Globus, G. Shaw, and S.R. Whittemore Distinct regulatory pathways control neurofilament expression and neurotransmitter synthesis in immortalized serotonergic neurons J. Neurosci. 14 1994 6744 6753
38. B.K. Yamamoto, and W. Zhu The effects of methamphetamine on the production of free radicals and oxidative stress J. Pharmacol. Exp. Ther. 287 1998 107 114
39. I. Ziv, R. Zilkha-Falb, D. Offen, A. Shirvan, A. Barzilai, and E. Melamed Levodopa induces apoptosis in cultured neuronal cells-a possible accelerator of nigrostriatal degeneration in Parkinson's disease? Mov. Disord. 12 1997 17 23